focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIofina Regulatory News (IOF)

Share Price Information for Iofina (IOF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 21.00
Bid: 20.00
Ask: 22.00
Change: 0.00 (0.00%)
Spread: 2.00 (10.00%)
Open: 21.00
High: 21.00
Low: 21.00
Prev. Close: 21.00
IOF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Q1 2024 Corporate Update

16 Apr 2024 07:00

RNS Number : 7098K
Iofina PLC
16 April 2024
 

16 April 2024

 

Iofina plc

("Iofina", the "Company" or the "Group")

(AIM: IOF)

 

Q1 2024 Corporate Update

IO#10 on Track

Renewal of Iodide Rich Brine Water Supply Agreements

 

Iofina plc, specialists in the exploration and production of iodine and manufacturers of specialty chemical products, today provides a brief update to the market regarding its activities during Q1 2024 (the "Period").

 

The Company continued to perform as expected during the Period, with Iofina Resources producing 123.7 metric tonnes ('MT') of crystalline iodine from its six IOsorb® iodine plants in Oklahoma. This was an increase of 15.5% from Q1 2023 (107.1 MT). Demand for Iofina's iodine remained strong throughout the Period and was supported by a further expansion in the customer base. The iodine spot price has remained steady in the mid to upper sixties per kg and prices are expected to remain at these levels in Q2 2024. The Company's sales channels remain robust, which is encouraging as it executes its production expansion plans.

 

Iofina's newest build, IO#10, is on track and progressing well. Dirt and concrete work are complete. Major components have been ordered, including the tower system which was sourced from an additional manufacturer to ensure ample supply from multiple vendors. The final steps for completion will focus on the tower installation, assembling buildings, plumbing, electricals and tying into our partner's brine system, which will happen during the early summer months. The Company continues to work on other growth projects and is in advanced dialogue with multiple partners for the next plant, IO#11.

 

 

Additionally, Iofina has signed new multi-year agreements for the supply of brine water to two of Iofina Resources' current IOsorb® plants. The new agreed terms, with one of Iofina's existing oil & gas partners, is an important milestone in maintaining consistent iodine production at both plants, whilst enabling our partners to maximise the supply of brine to these plants. The expectation remains that Iofina Resources will produce 275-295 MT of crystalline iodine during H1 2024 from its six existing plants (H1 2023: 241.5 MT). Iofina recognises that previous brine water supply fees for these two plants were lower than the standard market rates due to the historical nature of the contracts. Consequently, the new contracts carry higher fees than the previous agreements. The higher fee payments, which are effective 1 January 2024, will reduce EBITDA, and the Board expects FY 2024 EBITDA to be in the range of $8.5-$9.0 million. 

 

On the current timetable, IO#10 should make a healthy additional contribution for the H2 period and once operating, IO#10 is expected to produce 100-150MT of crystalline iodine per annum. The Company notes that it expects to publish its 2023 full-year financial results to the market in the coming weeks and hold its AGM in June 2024. 

 

Commenting, President and CEO, Dr. Tom Becker, stated:

"The Group has made a strong start to the year across its operations. We have experienced consistent iodine production with output meeting our targeted range and demand for our products continues to be strong. The construction of IO#10 is also on track and is expected to be completed in Q3 2024 on the current trajectory.

 

"It is important to have signed new agreements with our partner and secured future water supply to two IOsorb® plants. Guaranteeing this security means that Iofina can continue its future growth plans with confidence in our partners and focus on the development of new plants and products."

 

This announcement contains inside information for the purposes of article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018.

 

Enquiries:

 

Dr. Tom Becker

CEO & President

Iofina plc

Tel: +44 (0)20 3006 3135

 

Nomad & Broker:

Henry Fitzgerald-O'Connor/Harry Rees

Canaccord Genuity Limited

Tel: +44 (0)20 7523 8000

 

Media Contact:

Charles Goodwin/Shivantha Thambirajah

Yellow Jersey PR Limited

Tel: +44 (0)7747 788 221/+44 (0)7983 521 488

About Iofina:

Iofina plc (AIM: IOF) is a vertically integrated company that specialises in the production of Iodine and the manufacturing of specialty chemical products. Iofina is the second largest producer of iodine in North America and operates the manufacturing entities Iofina Resources and Iofina Chemical.

 

LEI: 213800QDMFYVRJYYTQ84

 

ISIN: GB00B2QL5C79

 

Iofina Resources

Iofina Resources develops, builds, owns, and operates iodine extraction plants using Iofina's WET® IOsorb® technology. Iofina currently operates five producing IOsorb® plants in Oklahoma and is consistently using technology and innovation to improve and expand its operations.

 

Iofina Chemical

Iofina Chemical has manufactured high quality halogen speciality chemicals derived from raw iodine, as well as non-iodine-based products. Iofina Chemical celebrated its 40th anniversary in 2023 as a preeminent halogen-based specialty chemicals company.

 

www.iofina.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFFFSISVIELIS
Date   Source Headline
22nd Sep 20207:00 amRNSDebt Refinancing Signed
26th Aug 20207:00 amRNSDebt Update
31st Jul 20208:00 amRNSLaunch of new website
22nd Jul 202011:06 amRNSSecond Price Monitoring Extn
22nd Jul 202011:00 amRNSPrice Monitoring Extension
22nd Jul 20207:00 amRNSCorporate Update
30th Jun 20202:36 pmRNSDebt Update
30th Jun 202011:52 amRNSResult of AGM
26th Jun 20201:26 pmRNSChange of venue for AGM on 30 June 2020
26th Jun 20207:00 amRNSIO#8 and Debt Update
27th May 20207:00 amRNSFinal Results
19th May 20204:41 pmRNSSecond Price Monitoring Extn
19th May 20204:36 pmRNSPrice Monitoring Extension
15th May 20204:40 pmRNSSecond Price Monitoring Extn
15th May 20204:35 pmRNSPrice Monitoring Extension
14th May 20207:00 amRNSPPP Loan Received
4th May 20207:00 amRNSIO#8 Brine Supply Update
14th Apr 20207:00 amRNSQ1 Market Update
2nd Apr 20207:00 amRNSDirectorate Change
26th Mar 20201:53 pmRNSWithdrawal of requisition for General Meeting
19th Mar 202012:08 pmRNSSecond Price Monitoring Extn
19th Mar 202012:03 pmRNSPrice Monitoring Extension
17th Mar 20204:41 pmRNSSecond Price Monitoring Extn
17th Mar 20204:35 pmRNSPrice Monitoring Extension
16th Mar 202012:07 pmRNSSecond Price Monitoring Extn
16th Mar 202012:02 pmRNSPrice Monitoring Extension
12th Mar 20204:41 pmRNSSecond Price Monitoring Extn
12th Mar 20204:36 pmRNSPrice Monitoring Extension
12th Mar 20201:56 pmRNSClarification Regarding Media Reports
11th Mar 202012:08 pmRNSSecond Price Monitoring Extn
11th Mar 202012:02 pmRNSPrice Monitoring Extension
10th Mar 20207:30 amRNSBoard response to recent GM request
10th Mar 20207:00 amRNSRequisition of General Meeting
3rd Mar 20207:10 amRNSStatement re: press and social media reports
2nd Mar 202012:22 pmRNSHolding(s) in Company
25th Feb 202012:00 pmRNSMarket Update
10th Feb 20205:15 pmRNSHolding(s) in Company
10th Feb 20205:15 pmRNSHolding(s) in Company
16th Jan 20207:00 amRNSMarket Update - Strong H2 2019
2nd Jan 202011:11 amRNSHolding(s) in Company
20th Dec 20197:00 amRNSTrading Update
14th Nov 20193:51 pmRNSHolding(s) in Company
14th Nov 20193:50 pmRNSHolding(s) in Company
12th Nov 20191:43 pmRNSHolding(s) in Company
6th Nov 20197:00 amRNSIofinaEX Hemp Seed Investment
14th Oct 20197:00 amRNSQ3 2019 Update
26th Sep 201910:00 amRNSHolding(s) in Company
25th Sep 20194:35 pmRNSPrice Monitoring Extension
23rd Sep 20197:00 amRNSInterim Results
18th Sep 20197:00 amRNSTerms for IO#8 Finalised - Construction Commences

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.